IRIS
LATTANZIO, ROSSANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.517
AS - Asia 3.190
EU - Europa 3.082
SA - Sud America 447
AF - Africa 80
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.331
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.401
SG - Singapore 1.419
IT - Italia 809
CN - Cina 729
IE - Irlanda 436
VN - Vietnam 384
BR - Brasile 373
SE - Svezia 305
RU - Federazione Russa 304
UA - Ucraina 247
GB - Regno Unito 240
DE - Germania 222
TR - Turchia 220
FR - Francia 183
IN - India 134
FI - Finlandia 94
CA - Canada 67
HK - Hong Kong 62
AT - Austria 47
JP - Giappone 38
PL - Polonia 35
ZA - Sudafrica 35
NL - Olanda 33
BD - Bangladesh 31
MX - Messico 29
AR - Argentina 27
CZ - Repubblica Ceca 27
IQ - Iraq 26
BE - Belgio 21
ES - Italia 21
EC - Ecuador 15
PH - Filippine 15
PK - Pakistan 14
KR - Corea 13
UZ - Uzbekistan 13
LT - Lituania 12
SA - Arabia Saudita 12
ID - Indonesia 11
TH - Thailandia 11
AU - Australia 10
MY - Malesia 9
MA - Marocco 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
EG - Egitto 7
KE - Kenya 7
TN - Tunisia 7
BG - Bulgaria 6
CO - Colombia 6
DZ - Algeria 6
HN - Honduras 6
IR - Iran 6
JO - Giordania 6
UY - Uruguay 6
PY - Paraguay 5
RS - Serbia 5
AO - Angola 4
BO - Bolivia 4
MO - Macao, regione amministrativa speciale della Cina 4
PT - Portogallo 4
RO - Romania 4
VE - Venezuela 4
AL - Albania 3
AZ - Azerbaigian 3
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
IL - Israele 3
KZ - Kazakistan 3
LB - Libano 3
NG - Nigeria 3
SR - Suriname 3
CL - Cile 2
CU - Cuba 2
DO - Repubblica Dominicana 2
EU - Europa 2
GD - Grenada 2
HR - Croazia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
Totale 11.324
Salva come PNG Salva come JPEG
Città #
Singapore 1.090
Chandler 498
San Jose 457
Dublin 427
Ashburn 399
Jacksonville 328
Beijing 215
Princeton 160
Santa Clara 153
Dallas 152
Los Angeles 149
Ho Chi Minh City 141
Southend 124
Pescara 113
Dearborn 112
New York 112
The Dalles 107
Izmir 102
Chieti 101
Nanjing 96
Ann Arbor 78
Altamura 73
Hanoi 73
Wilmington 73
Hong Kong 55
Munich 55
Boardman 54
Cambridge 50
Council Bluffs 48
Tongling 42
Moscow 41
Orem 41
São Paulo 41
Redondo Beach 39
Collecorvino 36
Dong Ket 34
Vienna 33
Denver 32
Rome 32
Nanchang 31
Milan 30
London 28
Johannesburg 27
Shenyang 27
Tokyo 27
Houston 26
Washington 26
Buffalo 25
Montreal 25
Brooklyn 24
Woodbridge 24
Warsaw 23
Chicago 22
Frankfurt am Main 21
Hebei 21
Hefei 21
Turku 21
Ancona 20
Chennai 20
Brussels 18
Stockholm 18
Amsterdam 17
Atlanta 17
Brno 17
Catania 17
Nuremberg 17
Helsinki 16
Jiaxing 16
Seattle 16
Tianjin 16
Boston 15
Da Nang 15
Lappeenranta 15
San Vito Chietino 15
Ankara 13
Haiphong 13
Mumbai 13
Poplar 13
Rio de Janeiro 13
Grevenbroich 12
Jinan 12
Manchester 12
Messina 12
Bologna 11
Phoenix 11
Seoul 11
Kunming 10
Tashkent 10
Toronto 10
Mexico City 9
Bangkok 8
Biên Hòa 8
Guayaquil 8
Medford 8
Norwalk 8
Campinas 7
Castignano 7
Changsha 7
Kraków 7
Oklahoma City 7
Totale 6.960
Salva come PNG Salva come JPEG
Nome #
A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer 252
Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology 242
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 215
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma 206
A unique four-hub protein cluster associates to glioblastoma progression 204
OXIDATIVE STRESS CAN DIFFERENTIALLY MODULATE WNT/β- CATENIN AND JNK SIGNALLING RELATIONSHIPS IN PRIMARY VERSUS METASTATIC CRC CELLS 185
Trop-2 is a determinant of breast cancer survival. 179
Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice 178
Molecular expression profiling shows pseudohypoxia phenotype, vasculogenesis and mitochondrial dysfunction in head and neck paragangliomas 170
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. 164
Trop-2 activates a dormant Na/K-ATPase/PKCa/CD9/ezrin signaling axis to override the basal growth program of cancer cells 163
ABCC3 is a novel target for the treatment of pancreatic cancer 161
Upregulation of Trop-2 quantitatively stimulates human cancer growth 159
Prognostic relevance of LGALS3BP in human colorectal carcinoma 159
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 158
The Trop-2 signalling network in cancer growth 155
Oxidative Stress Induces WNT Canonical/Non-Canonical Pathway Modulation in Colon Cancer Cells with APC or beta-Catenin Mutation 155
Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations 153
Exosomes as pleiotropic players in pancreatic cancer 153
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 149
Antagonist of growth hormone-releasing hormone MIA-690 attenuates the progression and inhibits growth of colorectal cancer in mice 149
Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression 146
Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8(+) T cell number and tumour growth in pancreatic cancer 146
Anomalous Fusion of Right Pulmonary Artery to Aortic Arch: Case Report of a Rare and Fatal Congenital Malformation in a Newborn and a Literature Review 146
Overexpression of PY1289-HER3 in sporadic pulmonary carcinoid from patients bearing MEN1 gene variants 145
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer 145
P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations 142
Molecular studies of pulmonary carcinoids 142
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 141
Trop-2 induces tumor growth through Akt and determines sensitivity to Akt inhibitors 139
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 139
The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. 136
Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease 134
[Tissue microarrays] 133
Proteomic meta-analysis unveils new frontiers for biomarkers research in pancreatic carcinoma 132
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction 132
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 132
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion 132
Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids 131
Methylation analysis of protocadherin genes in pancreatic adenocarcinoma 131
Inhibition of tumor growth and angiogenesis by SP-2, an anti-LGALS3BP antibody 130
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 129
Molecular expression profiling shows overlapping pseudohypoxia phenotype and mitochondrial dysfunction in head and neck paragangliomas 129
Vav1 down-modulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome 127
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody. 126
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading 125
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 124
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival 123
Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts. 123
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 120
Differential Regulation of Wingless-Wnt/c-Jun N-Terminal Kinase Crosstalk via Oxidative Eustress in Primary and Metastatic Colorectal Cancer Cells 120
The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle-invasive bladder cancer 116
mTrop1/Epcam Knockout Mice Develop Congenital Tufting Enteropathy through Dysregulation of Intestinal E-cadherin/β-catenin 115
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 115
Cyclin A2 maintains colon homeostasis and is a prognostic factor in CRC 112
Oxidative Distress Induces Wnt/β-Catenin Pathway Modulation in Colorectal Cancer Cells: Perspectives on APC Retained Functions 112
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody 111
NSC, SC and pleural screening of lung carcinoids for somatic mutations of MEN1 gene. 111
Pioneers in Pathology 111
LGALS3BP, A TUMOR-ASSOCIATED ANTIGEN, UPREGULATES VEGF IN HUMAN BREAST CANCER: POSSIBLE IMPLICATIONS IN ANGIOGENESIS 111
Role of phospholipase C in cell invasion and metastasis 110
Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer 109
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 109
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 108
Phospholipase Cgamma1 is required for metastasis development and progression 108
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals 108
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine 108
Intestinal tumour chemoprevention with the antioxidant lipoic acid stimulates the growth of breast cancer. 107
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 105
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process. 98
Loss of primary cilia promotes inflammation and carcinogenesis 97
The role of phospholipase Cγ1 in breast cancer and its clinical significance 97
3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability 93
Overexpression of activated phospholipase Cgamma1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy 90
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 90
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis. 89
Trop-2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis 89
Protective effects of growth hormone-releasing hormone analogs in DSS-induced colitis in mice 87
Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer 86
Effects of an ErbB-3 antibody, MP-RM-1, on tumor growth and ligand-dependent and -independent activation of ErbB-3/akt signaling 83
Natural compounds, antioxidant, and antiandrogens in the prevention of prostate cancer: in vivo evidences from murine models and human clinical studies. 82
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 81
Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer 81
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer 81
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 77
The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer 75
The HSP90/R2TP assembly chaperone promotes cell proliferation in the intestinal epithelium 74
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma 72
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer 68
Soft tissue integration of different abutment surfaces: An experimental study with histological analysis 66
Pancreatic beta-cell specific BAG3 knockout results in chronic hyperinsulinemia inducing insulin resistance 64
Wingless/It/β-catenin signaling in liver metastasis from colorectal cancer: A focus on biological mechanisms and therapeutic opportunities 64
null 56
Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes 48
null 40
Novel Ultrastructural Insights into the Clear-Cell Carcinoma of the Pancreas: A Case Report 38
Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker 35
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 28
Phylogenetic conservation of Trop-2 across species—rodent and primate genomics model anti-Trop-2 therapy for pre-clinical benchmarks 21
null 20
Totale 11.865
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.870
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.870
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021114 0 0 0 0 0 0 0 0 0 48 11 55
2021/2022512 17 7 25 126 14 47 10 24 31 22 64 125
2022/20231.337 104 236 78 135 138 219 69 121 138 17 42 40
2023/2024908 52 28 67 38 52 288 175 42 25 31 12 98
2024/20252.347 89 439 375 88 76 114 161 146 241 144 227 247
2025/20264.092 357 171 363 629 517 284 740 262 450 319 0 0
Totale 11.865